UKHSA announces blood and urine study of PFAS exposure
The UK Health Security Agency announced on 3 November 2026 a biomonitoring study measuring PFAS and other substances in blood and urine samples. It will use samples from the Health Survey for England.
The aim is to establish baseline exposure levels. Lead, arsenic, bisphenols, phthalates and flame retardants are also included, according to the agency.
UKHSA expects initial programme findings in 2027. Detecting a substance does not by itself establish an individual health risk: the agency points to gaps in understanding long-term effects and does not recommend routine PFAS blood screening.